A critical discovery in cancer investigation is occurring with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in many forms of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research